Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib plus Pembrolizumab in TNBC and Ovarian Cancer
NCT02657889Phase 2Completed
- Start
- Apr 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in triple-negative breast cancer (TNBC), ovarian cancer. Started Apr 2016; status: completed.
02
Drugs
niraparib
03
Conditions
triple-negative breast cancer (TNBC)ovarian cancer
Beyond the preview
Go deeper on NCT02657889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02657889.